Product
Cytotoxic Chemotherapy
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
A Randomized Open Label Phase II Trial of FDG-PET-Guided Metastasis Directed Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer: PRTY Trial: PET- Guided Radiotherapy ConsolidationStatus: Recruiting, Estimated PCD: 2027-02-18